Establishment of an Assay with Ultrahigh Sensitivity for Detecting sEV-Derived PD-L1 as a Serum Biomarker for Lung Cancer—A Pilot Study Using TN-cyclon™

Establishment of an Assay with Ultrahigh Sensitivity for Detecting sEV-Derived PD-L1 as a Serum Biomarker for Lung Cancer—A Pilot Study Using TN-cyclon™

Programmed death-ligand 1 (PD-L1) is an immune checkpoint protein. The soluble form of PD-L1 (sPD-L1) and PD-L1 derived from small extracellular vesicles (sEVPD-L1) are promising cancer biomarkers. While sEVPD-L1 in particular may contribute to immune evasion and is associated with a poor prognosis,...

Full description

Saved in:
Bibliographic Details
Main Authors: Kyo Okita, Hasumi Arita, Keita Sudo, Teruki Yoshimura, Etsuro Ito
Format: Article
Language:English
Published: MDPI AG 2025-07-01
Series:Current Issues in Molecular Biology
Subjects:
immune checkpoint
lung cancer
PD-L1
small extracellular vesicle
ultrasensitive ELISA
Online Access:https://www.mdpi.com/1467-3045/47/7/564
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items